Term ends no later than Sep 20, 2027 · Medium confidence
20-year base term ended Feb 12, 2024
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Feb 12, 2004
Sep 20, 2027
Dec 27, 2011
This patent's term runs 1316 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 12, 2004, when application 10/777,771, the earliest non-provisional in its chain, was filed (this one was filed Nov 10, 2006) | Feb 12, 2024 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1316 days, USPTO patent term adjustment record | Sep 20, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Sep 20, 2027 | Medium confidence |
Partial family
| US 6,907,293 | Term ended Nov 2023 | Nov 2023 |
| US 7,047,078 | Term ended Nov 2023 | Nov 2023 |
| US 7,120,499 | Term ended Jun 2024 | Jun 2024 |
| Application PCT/US2004/028322 | PCT application no patent term | no patent term |
| Application PCT/US2005/001017 | PCT application no patent term | no patent term |
| US 7,376,467 | Term ended Apr 2024 | Apr 2024 |
| Application PCT/US2005/004393 | PCT application no patent term | no patent term |
| US 7,623,925 | Lapsed on the fee record Nov 2021 | Nov 2021 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Feb 5, 2007 Reel 18894, frame 170 | Strother, Robert B.; Thrope, Geoffrey B.; Galecki, Steven M.; Mrva, Joseph J.; Pack, Danny R. | Ndi Medical, LLC | Assignment of Assignor's Interest |
| May 25, 2007 Reel 19341, frame 104 | Ndi Medical, LLC | Ndi Medical, Inc. | Assignment of Assignor's Interest |
| May 1, 2008 Reel 20886, frame 49 | Ndi Medical, Inc. | Ndi Medical, LLC | Assignment of Assignor's Interest |
| Feb 19, 2009 Reel 22277, frame 619 | Ndi Medical LLC - Charter No. 1296496 | Ndi Medical, LLC - Charter No. 1766209 | Assignment of Assignor's Interest |
| Mar 2, 2011 Reel 25882, frame 789 | Ndi Medical, LLC | National Institutes of Health (Nih), U.S. Dept. of Health and Human Services (DHHS), U.S. Government | Confirmatory License |
| Sep 24, 2014 Reel 33809, frame 771 | SPR Therapeutics, LLC | Ohio Development Services Agency | Security Interest |
| Aug 31, 2017 Reel 43746, frame 882 | Ndi Medical, LLC | SPR Therapeutice, LLC | Assignment of Assignor's Interest |
| Oct 5, 2017 Reel 44128, frame 118 | Ndi Medical, LLC | SPR Therapeutics, LLC | Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 043746 Frame: 0882. Assignor(S) Hereby Confirms the Assignment. |
| Nov 9, 2017 Reel 44715, frame 395 | SPR Therapeutics, Inc. | The Director of the Ohio Development Services Agency | Security Interest |
| Dec 6, 2017 Reel 44716, frame 812 | SPR Therapeutics, LLC | SPR Therapeutics, Inc. | Change of Name |
| Oct 15, 2019 Reel 50728, frame 721 | The Director of the Ohio Development Services Agency | SPR Therapeutics, Inc. | Release of Security Interest |
| Jan 30, 2024 Reel 66381, frame 75 | SPR Therapeutics, Inc. | SLR Investment Corp., as Agent | Intellectual Property Security Agreement |
| Jan 30, 2024 Reel 66412, frame 400 | SPR Therapeutics, Inc. | Gemino Healthcare Finance, LLC | Security Interest |
| Feb 8, 2024 Reel 66526, frame 25 | The Director of Development, State of Ohio, Formerly Known as the Director of the Ohio Development Services Agency | SPR Therapeutics, Inc., Formerly Known as SPR Therapeutics, LLC | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 374 | Gemino Healthcare Finance, LLC, D/B/A SLR Healthcare ABL | SPR Therapeutics, Inc. | Release of Security Interest |
| Jul 15, 2026 Reel 75985, frame 409 | SLR Investment Corp., as Agent | SPR Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Sep 20, 2027. We will not guess the cap.